"/> Tocris Bioscience™ Ibrutinib | B-LABO France

Tocris Bioscience™ Ibrutinib

Réf. : BL-RE-125924Réf. fabricant : 18757926 10 mg
201,94 € HT

Potent and selective BTK inhibitor (IC50= 0.5 nM)

Nom chimique ou matériau
1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
CAS
936563-96-1
Synonyme
Agammaglobulinaemia tyrosine kinase, AGMX1, ATKIMD1, B-cell progenitor kinase, BPK, Bruton agammaglobulinemia tyrosine kinase, Bruton tyrosine kinase, dominant-negative kinase-deficient Brutons tyrosine kinase, tyrosine-protein kinase
Quantité
10 mg
Formule moléculaire
C25H24N6O2
Marque
Tocris Bioscience

Ibrutinib is a potent and selective BTK inhibitor (IC50= 0.5 nM). Selective for BTK against a screening panel of kinase enzymes. Inhibits autophosphorylation of BTK, phosphorylation of PLCγ, and phosphorylation of ERK (IC50 of 11 nM, 29 nM and 13 nM, respectively). Also inhibits ErbB4 (IC50 = 0.25-3.4 nM). Induces cytotoxicity of chronic lymphocytic leukemia (CLL) cells. Reduces clinical arthritis scores in a mouse model.

Caractéristiques techniques

MarqueTocris Bioscience
Réf. B-LABOBL-RE-125924
Réf. fabricant18757926
Nom chimique ou matériau1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
CAS936563-96-1
SynonymeAgammaglobulinaemia tyrosine kinase, AGMX1, ATKIMD1, B-cell progenitor kinase, BPK, Bruton agammaglobulinemia tyrosine kinase, Bruton tyrosine kinase, dominant-negative kinase-deficient Brutons tyrosine kinase, tyrosine-protein kinase
Quantité10 mg
Formule moléculaireC<sub>25</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub>
Poids de la formule440.5
Pureté98%
Une question, une configuration particulière ?
Contactez-nous pour un devis.